An experimental coronavirus vaccine from Oxford University shows promise, according to findings from a small study in six monkeys.
Researchers reported at least some of the monkeys developed antibodies to the virus within 14 days of being vaccinated, and all of the vaccinated animals had evidence of antibodies within 28 days.What's more, researchers said the vaccine appears to have prevented pneumonia and other lung problems in the animals after they were exposed to the coronavirus.
Still, there is no guarantee the Oxford vaccine will ultimately prove to be successful. Studies in humans are ongoing, and this research team is one of several around the globe working at an accelerated pace to find a safe and effective vaccine for the coronavirus. But so far, the Oxford vaccine appears to hold the most promise of becoming the first vaccine to be widely accessible, if proven to work.
Oxford scientists previously said they hope to have enough data to show the vaccine is effective by the beginning of June, and predicted the vaccine could be produced by September.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Vaccine Maker Moderna Moves to Next Phase of TestingModerna’s COVID-19 Vaccine Moves to Phase 2 Testing, and Gets Fast-Track Approval from the U.S. Government
Weiterlesen »
Scientists race to find a cure or vaccine for the coronavirus. Here are the top drugs in developmentThere are more than 100 vaccines in development globally as of April 30 with at least eight vaccine candidates already in human trials.
Weiterlesen »
Ahmaud Arbery's Mom Says Racism is Still Rampant in Small U.S. TownsAhmaud Arbery's mother believes his murder shows racism's thriving in America, especially in some small towns.
Weiterlesen »
Twin antibodies may help fight coronavirus; normal speech may spread virusThe following is a brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Weiterlesen »
CureVac's coronavirus vaccine candidate triggered immune response in animal testsGermany's unlisted CureVac said its experimental coronavirus vaccine was shown to trigger an immune response in animals when given a low dose and the biotech firm was looking at carrying out its first human trials in June.
Weiterlesen »
White House names heads of 'warp speed' coronavirus vaccine effortMoncef Slaoui, the ex-head of GlaxoSmithKline's vaccines division, has been tapped to lead President Donald Trump's 'warp speed' effort to develop a coronavirus vaccine, two White House officials said Wednesday.
Weiterlesen »